---
# Feel free to add content and custom Front Matter to this file.
# To modify the layout, see https://jekyllrb.com/docs/themes/#overriding-theme-defaults

layout: splash
tagline: Revolutionizing Radioisotope Production

header:
  overlay_color: "#684AA5"
  overlay_filter: 0.3

feature_row:
  - image_path: assets/images/Crystals.jpg
    alt: "placeholder image 1"
    title: "Broad Range of Products"
    excerpt: Our capability to produce several otherwise unavailable or economically unfeasible radioisotopes
             will expand the market and enable the development of radiopharmaceutical for personalized cancer therapies,
    url: "/products/"
    btn_label: "See Applications"
    btn_class: "btn--primary"

  - image_path: /assets/images/Alpha.jpg
    image_caption: "[Image by Nusano]"
    alt: "placeholder image 2"
    title: "Industrial Radioisotope Production"
    excerpt: Declining global supply of radioisotopes had led to a global shortage. Market analysis indicates a need for high volume production that does not depend on regulated uranium sources.
    url: "/development/"
    btn_label: "Read Whitepaper"
    btn_class: "btn--primary"

  - image_path: /assets/images/Source.jpg
    image_caption: "[Image by Nusano]"
    alt: "placeholder image 3"
    title: Unique technology
    excerpt: Our patented, breakthrough particle beam technology generates alpha particles at levels thousands of times greater than any existing particle source.
             No other production method comes close to the yield, performance, cost, reliability, flexibiilty, and eco-friendliness."
    url: "/development/"
    btn_label: "Learn more about the technology"
    btn_class: "btn--primary"

outro:
  - image_path:
    alt: "placeholder image 2"
    title: "Questions"
    url: "/contact/"
    btn_label: "Contact Us"
    btn_class: "btn--primary"
---

# WHO WE ARE
Nusano is a private company that intends to bring stability to the underserved market of radioisotopes.
We have developed a high current ion source and linear accelerator that allows us to remove the current limitations of radioisotopes manufacturing for medical application and innovation.
The facility will include full processing for cGMP radioisotope production.

{% include feature_row id="learn_more" %}

# OUR ADVANTAGES

{% include feature_row id="feature_row"%}
